Mirae Asset Global ETFs Holdings’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-23,246
Closed -$31.1K 3328
2026
Q1
$31.1K Buy
23,246
+544
+2% +$1.08K ﹤0.01% 2990
2025
Q4
$55.6K Buy
22,702
+307
+1% +$1.33K ﹤0.01% 2908
2025
Q3
$150K Sell
22,395
-3,708
-14% -$24.2K ﹤0.01% 2469
2025
Q2
$153K Sell
26,103
-3,146
-11% -$20.5K ﹤0.01% 2404
2025
Q1
$245K Buy
29,249
+1,248
+4% +$11.2K ﹤0.01% 2221
2024
Q4
$208K Buy
28,001
+1,216
+5% +$8.14K ﹤0.01% 2372
2024
Q3
$155K Buy
26,785
+4,007
+18% +$25.7K ﹤0.01% 2494
2024
Q2
$151K Buy
+22,778
New +$184K ﹤0.01% 2387

Other funds holding TMCI

Mirae Asset Global ETFs Holdings's TMCI Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 23,246 shares — an estimated $31.1K sold.

Mirae Asset Global ETFs Holdings first reported a position in TMCI in Q2 2024 and held it in 8 quarters. The position peaked at $245K in Q1 2025. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 23,246 Treace Medical Concepts shares in Q2 2026, an estimated $31.1K.
  • Mirae Asset Global ETFs Holdings first reported a position in Treace Medical Concepts in Q2 2024 and held it in 8 quarters.
  • Mirae Asset Global ETFs Holdings's Treace Medical Concepts position peaked at $245K in Q1 2025.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.